Invigor to roll out popular Chinese payment platform Alipay


Published 03-OCT-2018 12:41 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Data solutions company, Invigor Group Limited (ASX:IVO), has reached an agreement with China’s Winning Group Holdings Limited to distribute and expand Alipay services in the Hong Kong region.

IVO previously announced a binding MOU with China’s Winning Group to oversee and expand WeChat pay services in South-East Asia on September 18.

Alipay is a third-party mobile platform that has quickly become one of the most popular payment methods in Asia. The online payment gateway is one of the world’s highest valued fintech companies, coming in at over US$150 billion.

Thanks to this latest agreement, IVO and Winning Group are primed to grow the payment services market share in South-East Asia via its already established presence.

IVO CEO Gary Cohen commented on the encouraging news, “Alipay and WeChat pay account for most of the payment transactions in Asia.

“Winning Group has once again provided us with great opportunities to distribute and expand services across regions in which we already have a strong presence.”

At the same time, it’s worth noting that this is an early stage play and investors should seek professional financial advice if considering this company for their portfolio.

The company’s revenue share is outlined in the 18 September ASX announcement, but will be based on a percentage of the transaction revenue generated.

Additional details on the opportunity will be provided on the WeChat Update – Investor Web Conference Call, which will commence on October 8 2018 at 2pm AEST.

To attend, click the following link:

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free